Arvinas, Inc. (ARVN)

Nasdaq: ARVN · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2015

Grade5.7

◀ Past 6.6● Present 6.0▶ Future 4.5

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Report filed	Feb 24, 2026	Feb 11, 2025	Feb 27, 2024	Feb 23, 2023	Feb 28, 2022	Mar 1, 2021	Mar 16, 2020	Mar 26, 2019	·
Revenue	262,600,000	263,400,000	78,500,000	131,400,000	53,600,000^r	25,900,000^r	43,000,000^r	14,323,920	7,578,876
Research and development	285,200,000	348,200,000	379,700,000	315,000,000	180,400,000	108,400,000^r	67,200,000^r	45,193,830	28,792,902
General and administrative	95,900,000	165,400,000	100,300,000	79,600,000	61,600,000	38,300,000^r	27,300,000^r	12,932,168	3,546,241
Total operating expenses	381,100,000	513,600,000	480,000,000	394,600,000	242,000,000	146,700,000^r	94,500,000^r	58,125,998	32,339,143
Operating income	-118,500,000	-250,200,000	-401,500,000	-263,200,000	-188,400,000^r	-120,800,000^r	-51,500,000^r	-43,802,078	-24,760,267
Interest expense	·	0	0	0	0	100,000^r	100,000^r	57,440	50,357
Interest and investment income	38,400,000	54,800,000	38,800,000	12,000,000	1,800,000^r	3,500,000^r	4,600,000^r	2,470,101	201,388
Share of profit of equity-method investments	0	0	-2,500,000	-10,600,000	-6,900,000^r	-4,100,000^r	-24,700,000^r	0	·
Other income (expense), net	-400,000	-2,900,000	-1,200,000	200,000	2,500,000	2,100,000^r	1,400,000^r	102,730	554,159
Total non-operating income (expense)	38,000,000	51,900,000	37,600,000	12,200,000	4,300,000	5,600,000^r	5,900,000^r	2,321,612	711,061
Income before income taxes	-80,500,000	-198,300,000	-363,900,000	-251,000,000	-184,100,000	-115,200,000	·	·	·
Income tax expense	300,000	600,000	900,000	20,900,000	0	0	0	0	0
Net income including non-controlling interests	·	·	·	·	-191,000,000	-119,300,000^r	-70,300,000^r	-41,480,466	-24,049,206
Net income	-80,800,000	-198,900,000	-367,300,000	-282,500,000	-191,000,000	-119,300,000^r	-70,300,000^r	-41,480,466	-24,049,206
Net income to common shareholders	·	·	·	·	·	-119,332,064	-70,292,227	-239,847,222	-28,619,637
Earnings per share, basic	-1.14	-2.77	-6.62	-5.31	-3.82	-3.02	-2.13	·	·
Earnings per share, diluted	-1.14	-2.77	-6.62	-5.31	-3.82	-3.02	-2.13	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-3.02	-2.13	-25.45	-15.08
Weighted average shares, basic	70,900,000	71,900,000	55,500,000	53,200,000	50,000,000	39,500,000	32,900,000	·	·
Weighted average shares, diluted	70,900,000	71,900,000	55,500,000	53,200,000	50,000,000	39,500,000	32,900,000	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	39,534,497	32,927,697	9,422,799	1,897,544

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldus-gaap:Revenues

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing cost

us-gaap:InterestExpense
us-gaap:InterestExpenseDebt

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton ARVN · research, not advice